\-\ Texto\\:\\ \ \(0\)\
\-\ dry\\ mucous\\ membranes\\ with\\ evidence\\ of\\ recent\\ mucositis\\.\\ diffuse\\ rash\\.\ \(0\)\
\-\ wbc\\:\\ 15\\.3\\,\\ anc\\:\\ 10\\.9\\,\\ hgb\\:\\ 15\\.3\\,\\ plts\\:\\ 131\ \(0\)\
\-\ ciprofloxacin\\,\\ ditropan\\ and\\ pyridium\\.\\ \ \(0\)\
\-\ acyclovir\\,\\ biotene\\,\\ mycelex\\,\\ pentamidine\\ and\\ voriconazole\\ \ \(0\)\
\-\ monthly\\ dose\\ ivgg\\ \\(goal\\ igg\\ \\>1000\\)\\ \ \(0\)\
\-\ tacrolimus\\ and\\ keppra\\ \\(seizure\\ prophylaxis\\)\ \(0\)\
\-\ prednisone\ \(35\)\
\-\ \\*\\ enhancement\\ of\\ gallbladder\\ wall\ \(0\)\
\-\ \\*\\ diffuse\\ enhancement\\ of\\ walls\\ of\\ entire\\ colon\\ with\\ bowel\\ wall\\ thickening\\ \ \(0\)\
\-\ \\*\\ inflammatory\\ changes\\ and\\ free\\ fluid\\ in\\ right\\ paracolic\\ gutter\\ \ \(0\)\
\-\ \\*\\ high\\ attenuation\\ of\\ spleen\ \(0\)\
\-\ graft\\ vs\\ host\\ \\(gvhd\\)\\ of\\ the\\ skin\\ and\\ gi\\ system\\.\ \(0\)\
\-\ \\*\\ pseudomembranous\\ colitis\\ \ \(0\)\
\-\ \\*\\ typhilitis\\ \ \(0\)\
\-\ \\*\\ cmv\\ colitis\\ \ \(0\)\
\-\ \\*\\ shock\\ bowel\ \(0\)\
\-\ 12\\ y\\.o\\.\\ girsl\\ with\\ sickle\\-cell\\ disease\\ s\\/p\\ bone\\ marrow\\ transplantation\\ from\\ her\\ sibling\\ 36\\ days\\ prior\\.\\ hemorrhagic\\ cystitis\\.\ \(0\)\
\-\ colonoscopy\\ with\\ biopsy\\.\\ findings\\ revealed\\ acute\\ colitis\\ with\\ ulceration\\.\\ no\\ increase\\ in\\ epithelial\\ apoptosis\\ in\\ the\\ crypts\\ as\\ would\\ be\\ expected\\ in\\ gvhd\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gvhd\\:\\ 0\\.2827189077895796\ \(0\)\
\-\ colitis\\:\\ 0\\.2622460334170457\ \(0\)\
\-\ mucositis\\:\\ 0\\.1413594538947898\ \(0\)\
\-\ ditropan\\:\\ 0\\.1413594538947898\ \(0\)\
\-\ biotene\\:\\ 0\\.1413594538947898\ \(0\)\
\-\ mycelex\\:\\ 0\\.1413594538947898\ \(0\)\
\-\ ivgg\\:\\ 0\\.1413594538947898\ \(0\)\
\-\ typhilitis\\:\\ 0\\.1413594538947898\ \(0\)\
\-\ girsl\\:\\ 0\\.1413594538947898\ \(0\)\
\-\ crypts\\:\\ 0\\.1413594538947898\ \(0\)\
\-\ anc\\:\\ 0\\.13507650483138792\ \(0\)\
\-\ pyridium\\:\\ 0\\.13507650483138792\ \(0\)\
\-\ pentamidine\\:\\ 0\\.13507650483138792\ \(0\)\
\-\ tacrolimus\\:\\ 0\\.13507650483138792\ \(0\)\
\-\ voriconazole\\:\\ 0\\.13061868152791822\ \(0\)\
\-\ apoptosis\\:\\ 0\\.12716092514223246\ \(0\)\
\-\ keppra\\:\\ 0\\.12194706609082417\ \(0\)\
\-\ paracolic\\:\\ 0\\.12194706609082417\ \(0\)\
\-\ ciprofloxacin\\:\\ 0\\.11987790916104667\ \(0\)\
\-\ plts\\:\\ 0\\.11805278340111446\ \(0\)\
\-\ sibling\\:\\ 0\\.11642015277536087\ \(0\)\
\-\ acyclovir\\:\\ 0\\.11359496009764478\ \(0\)\
\-\ monthly\\:\\ 0\\.11359496009764478\ \(0\)\
\-\ gutter\\:\\ 0\\.11359496009764478\ \(0\)\
\-\ host\\:\\ 0\\.11359496009764478\ \(0\)\
\-\ bowel\\:\\ 0\\.11345328772976947\ \(0\)\
\-\ pseudomembranous\\:\\ 0\\.1112062937239526\ \(0\)\
\-\ diffuse\\:\\ 0\\.11086654991963449\ \(0\)\
\-\ wall\\:\\ 0\\.10754081778443819\ \(0\)\
\-\ 1000\\:\\ 0\\.1056793804084893\ \(0\)\
\-\ igg\\:\\ 0\\.10420248636024854\ \(0\)\
\-\ cystitis\\:\\ 0\\.10420248636024854\ \(0\)\
\-\ of\\:\\ 0\\.10378856898416648\ \(0\)\
\-\ transplantation\\:\\ 0\\.1028541877307732\ \(0\)\
\-\ enhancement\\:\\ 0\\.10175480281184265\ \(0\)\
\-\ shock\\:\\ 0\\.10161387322490593\ \(0\)\
\-\ goal\\:\\ 0\\.10046552135708103\ \(0\)\
\-\ cmv\\:\\ 0\\.09888833143100094\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.0974569459588738\ \(0\)\
\-\ ulceration\\:\\ 0\\.09657123866737133\ \(0\)\
\-\ rash\\:\\ 0\\.09533092416150404\ \(0\)\
\-\ epithelial\\:\\ 0\\.09493860804161773\ \(0\)\
\-\ 131\\:\\ 0\\.09346171399337697\ \(0\)\
\-\ dry\\:\\ 0\\.09311348228168553\ \(0\)\
\-\ prednisone\\:\\ 0\\.09311348228168553\ \(0\)\
\-\ membranes\\:\\ 0\\.09277290463734114\ \(0\)\
\-\ graft\\:\\ 0\\.09211341536390164\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.09211341536390164\ \(0\)\
\-\ and\\:\\ 0\\.0913265294597845\ \(0\)\
\-\ mucous\\:\\ 0\\.09117399689547191\ \(0\)\
\-\ in\\:\\ 0\\.08795711658061316\ \(0\)\
\-\ with\\:\\ 0\\.08654215219116923\ \(0\)\
\-\ spleen\\:\\ 0\\.08604719233723745\ \(0\)\
\-\ hgb\\:\\ 0\\.08583046630049976\ \(0\)\
\-\ walls\\:\\ 0\\.08289803680013444\ \(0\)\
\-\ dose\\:\\ 0\\.08254584757111105\ \(0\)\
\-\ entire\\:\\ 0\\.08043322452860034\ \(0\)\
\-\ expected\\:\\ 0\\.07969166394194697\ \(0\)\
\-\ gallbladder\\:\\ 0\\.07898397662333789\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.07667457210547701\ \(0\)\
\-\ gi\\:\\ 0\\.07425188670817832\ \(0\)\
\-\ seizure\\:\\ 0\\.07355421509337706\ \(0\)\
\-\ marrow\\:\\ 0\\.07345706330787459\ \(0\)\
\-\ 36\\:\\ 0\\.0731692099710451\ \(0\)\
\-\ increase\\:\\ 0\\.07095810708048618\ \(0\)\
\-\ free\\:\\ 0\\.0688067448702263\ \(0\)\
\-\ attenuation\\:\\ 0\\.06763279303122441\ \(0\)\
\-\ vs\\:\\ 0\\.06743455161916345\ \(0\)\
\-\ system\\:\\ 0\\.06743455161916345\ \(0\)\
\-\ colon\\:\\ 0\\.0673037857880366\ \(0\)\
\-\ skin\\:\\ 0\\.06575602732195149\ \(0\)\
\-\ would\\:\\ 0\\.06257169587287706\ \(0\)\
\-\ wbc\\:\\ 0\\.06247604335291964\ \(0\)\
\-\ biopsy\\:\\ 0\\.06196025519306443\ \(0\)\
\-\ 12\\:\\ 0\\.06042477635281332\ \(0\)\
\-\ thickening\\:\\ 0\\.060135129433132234\ \(0\)\
\-\ recent\\:\\ 0\\.05985079743685397\ \(0\)\
\-\ inflammatory\\:\\ 0\\.05977050886848102\ \(0\)\
\-\ revealed\\:\\ 0\\.0579587356807055\ \(0\)\
\-\ days\\:\\ 0\\.05595651474714426\ \(0\)\
\-\ her\\:\\ 0\\.05522285540602403\ \(0\)\
\-\ changes\\:\\ 0\\.05342096898910925\ \(0\)\
\-\ fluid\\:\\ 0\\.051036100105701726\ \(0\)\
\-\ high\\:\\ 0\\.05023671982872082\ \(0\)\
\-\ evidence\\:\\ 0\\.050171929522362435\ \(0\)\
\-\ prior\\:\\ 0\\.04945597010580027\ \(0\)\
\-\ bone\\:\\ 0\\.04822990885161617\ \(0\)\
\-\ acute\\:\\ 0\\.04781716714018057\ \(0\)\
\-\ findings\\:\\ 0\\.043625430376257865\ \(0\)\
\-\ disease\\:\\ 0\\.03710418968484926\ \(0\)\
\-\ be\\:\\ 0\\.035857456542081514\ \(0\)\
\-\ as\\:\\ 0\\.03551055588471195\ \(0\)\
\-\ the\\:\\ 0\\.03527516379276493\ \(0\)\
\-\ from\\:\\ 0\\.03510590337163718\ \(0\)\
\-\ right\\:\\ 0\\.029305896134869776\ \(0\)\
\-\ no\\:\\ 0\\.02874435788055655\ \(0\)\
